Xu Jian Fang
Xu Jian Fang — Chief Physician — Oncology — Shanghai Pulmonary Hospital
Specialties
Individualized comprehensive treatment for advanced lung cancer, palliative care, psychological therapy for cancer patients, targeted therapy
Education
Graduated from Shanghai Second Medical University in 1987
Professional Experience
Xu Jianfang, female, chief physician, graduated from Shanghai Second Medical University in 1987. She has been engaged in the clinical work of diagnosing, differentiating, and treating respiratory diseases for nearly 30 years. She is proficient in handling common and complex respiratory diseases and is skilled in various pulmonary procedures. She keeps up with the latest research developments in the diagnosis and treatment of lung cancer both domestically and internationally. Currently, her main research focuses are on individualized treatment and molecular targeted therapy for lung cancer, while promoting communication and cooperation between relevant institutions at home and abroad. She is responsible for lecturing in the national continuing education program 'New Advances in Lung Cancer,' as well as giving academic lectures, radio talks, and departmental lectures. She has chaired the Wu Jieping Foundation and participated in the National 863 Program, Shanghai Science and Technology Commission Mountain Climbing Plan and major research projects, the National Natural Science Foundation, the Shanghai Natural Science Foundation, and research projects of the Health Bureau. She has also participated in numerous international and domestic multicenter clinical trials and contributed to lung cancer publicity manuals. She has received multiple awards at the national level in China and has been honored as a March 8 Red Flag Bearer by the Shanghai Health Bureau and her hospital.
Professional Roles
Member of CSCOASCO, Member of the Medical Accident and Judicial Appraisal Expert Committee of Shanghai Medical Association, Member of the Lung Tumor Association of the China Medical Education Association, Member of the Respiratory Professional Committee, and Member of the Lung Cancer Study Group.